A detailed history of Orion Capital Management LLC transactions in Synaptogenix, Inc. stock. As of the latest transaction made, Orion Capital Management LLC holds 2,000 shares of SNPX stock, worth $8,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$8,300
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$0.28 - $1.04 $560 - $2,080
2,000 New
2,000 $0
Q1 2023

May 09, 2023

SELL
$0.8 - $1.33 $1,600 - $2,660
-2,000 Reduced 50.0%
2,000 $1,000
Q4 2021

Feb 07, 2022

BUY
$8.38 - $13.72 $33,520 - $54,880
4,000 New
4,000 $34,000

Others Institutions Holding SNPX

About Synaptogenix, Inc.


  • Ticker SNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,840,630
  • Market Cap $28.4M
  • Description
  • Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...
More about SNPX
Track This Portfolio

Track Orion Capital Management LLC Portfolio

Follow Orion Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Capital Management LLC with notifications on news.